相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables
C. A. Siegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
N. S. Ding et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice
Emily E. Vivio et al.
JOURNAL OF CROHNS & COLITIS (2016)
Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease
N. To et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study
D. C. Baumgart et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease
Parambir S. Dulai et al.
INFLAMMATORY BOWEL DISEASES (2016)
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease
Brigid S. Boland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Comparative Effectiveness of Immunosuppressants and Biologics for Inducing and Maintaining Remission in Crohn's Disease: A Network Meta-analysis
Glen S. Hazlewood et al.
GASTROENTEROLOGY (2015)
Assessment of mucosal healing in inflammatory bowel disease: review
Parambir S. Dulai et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort
Edward Shelton et al.
INFLAMMATORY BOWEL DISEASES (2015)
Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease
Jean-Frederic Colombel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Risks of Serious Infection or Lymphoma With Anti-Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review
Parambir S. Dulai et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Effects of Vedolizumab Induction Therapy for Patients With Crohn's Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
Bruce E. Sands et al.
GASTROENTEROLOGY (2014)
Development of Drugs to Target Interactions Between Leukocytes and Endothelial Cells and Treatment Algorithms for Inflammatory Bowel Diseases
Silvio Danese et al.
GASTROENTEROLOGY (2014)
The Risk of Malignancy Associated with the Use of Biological Agents in Patients with Inflammatory Bowel Disease
Parambir S. Dulai et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2014)
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
Laurent Peyrin-Biroulet et al.
GUT (2014)
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
Parambir S. Dulai et al.
GUT (2014)
Comparative Efficacy of Biologic Therapy in Biologic-Naive Patients With Crohn Disease: A Systematic Review and Network Meta-analysis
Siddharth Singh et al.
MAYO CLINIC PROCEEDINGS (2014)
The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcerative Colitis
Brian G. Feagan et al.
GASTROENTEROLOGY (2013)
Effect of Tumor Necrosis Factor-α Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease
Paolo Biancheri et al.
INFLAMMATORY BOWEL DISEASES (2013)
Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S. Schreiber et al.
JOURNAL OF CROHNS & COLITIS (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population
Christina Ha et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Current smoking differentially affects blood mononuclear cells from patients with crohn's disease and ulcerative colitis: Relevance to its adverse role in the disease
Vivianne Bergeron et al.
INFLAMMATORY BOWEL DISEASES (2012)
Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: Biological roles and effects of TNF and TNF antagonists
Yehuda Chowers et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
分享论文
